More Radiation, Less Progression in Non-Hodgkin's LymphomaMore Radiation, Less Progression in Non-Hodgkin's Lymphoma

Patients receiving I-131 radioimmunotherapy who received more than 200 cGy to tumors had significantly longer progression-free survival. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Radiology News Source Type: news